Literature DB >> 15358285

Tumor promoter binding of the protein kinase C C1 homology domain peptides of RasGRPs, chimaerins, and Unc13s.

Kazuhiro Irie1, Akiko Masuda, Mayumi Shindo, Yu Nakagawa, Hajime Ohigashi.   

Abstract

Recent investigations discovered nonkinase-type phorbol ester receptors, RasGRPs, chimaerins, and Unc13s. Phorbol ester binding occurs at the cysteine-rich sequences of about 50 residues in the C1 domains of these receptors. Fifty-one-residue RasGRP C1 peptides except for RasGRP2 showed significant phorbol 12,13-dibutyrate (PDBu) binding, but the K(d) values of the RasGRP1 and RasGRP3 C1 peptides were about 10-fold larger than those for the corresponding whole enzymes. Addition of the C-terminal basic amino acid cluster decreased their K(d) values about 10-fold, suggesting that the positive charges of these C1 peptides play an important role in the PDBu binding in the presence of negatively-charged phosphatidylserine. The 51-mer chimaerin C1 peptides showed potent PDBu binding, while the Unc13 and Munc13-1 C1 peptides without sufficient positive charges hardly bound PDBu. By the rapid screening system using this C1 peptide library, 5-prenyl-indolactam-V was identified as a promising lead for the novel protein kinase C isozyme specific ligands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358285     DOI: 10.1016/j.bmc.2004.07.008

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

Review 1.  CalDAG-GEFI and platelet activation.

Authors:  Lucia Stefanini; Wolfgang Bergmeier
Journal:  Platelets       Date:  2010       Impact factor: 3.862

Review 2.  RAP1-GTPase signaling and platelet function.

Authors:  Lucia Stefanini; Wolfgang Bergmeier
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

3.  Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells.

Authors:  James C Stone
Journal:  Genes Cancer       Date:  2011-03

4.  Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity.

Authors:  Agnes Czikora; Daniel J Lundberg; Adelle Abramovitz; Nancy E Lewin; Noemi Kedei; Megan L Peach; Xiaoling Zhou; Raymond C Merritt; Elizabeth A Craft; Derek C Braun; Peter M Blumberg
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

5.  RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.

Authors:  Courtney T Luke; Carolyn E Oki-Idouchi; J Mark Cline; Patricia S Lorenzo
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

6.  Critical Role of Trp-588 of Presynaptic Munc13-1 for Ligand Binding and Membrane Translocation.

Authors:  Joydip Das; Noemi Kedei; Jessica S Kelsey; Youngki You; Satyabrata Pany; Gary A Mitchell; Nancy E Lewin; Peter M Blumberg
Journal:  Biochemistry       Date:  2018-01-05       Impact factor: 3.162

7.  Differential membrane binding and diacylglycerol recognition by C1 domains of RasGRPs.

Authors:  Joanne E Johnson; Rebecca E Goulding; Ziwei Ding; Amir Partovi; Kira V Anthony; Nadine Beaulieu; Ghazaleh Tazmini; Rosemary B Cornell; Robert J Kay
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

8.  Role of chimaerins, a group of Rac-specific GTPase activating proteins, in T-cell receptor signaling.

Authors:  María José Caloca; Pilar Delgado; Balbino Alarcón; Xosé R Bustelo
Journal:  Cell Signal       Date:  2007-12-28       Impact factor: 4.315

Review 9.  RAP GTPases and platelet integrin signaling.

Authors:  Lucia Stefanini; Wolfgang Bergmeier
Journal:  Platelets       Date:  2018-06-04       Impact factor: 3.862

10.  Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.

Authors:  Sung Hee Choi; Gabriella Czifra; Noemi Kedei; Nancy E Lewin; Jozsef Lazar; Yongmei Pu; Victor E Marquez; Peter M Blumberg
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.